Navigation Links
Benefit of targeted lung cancer therapy confirmed
Date:6/3/2011

AURORA, Colo. (June 3, 2011) A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).

The patients taking crizotinib have anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) and the drug targets the gene that drives this particular kind of cancer. In 119 patients, crizotinib produces some degree of shrinkage in the tumors of the majority of patients with dramatic responses in more than 60 percent of cases. The responses last approximately 48 weeks.

D. Ross Camidge, MD, PhD, the director of the lung cancer clinical program at University of Colorado Hospital (UCH) and the University of Colorado Cancer Center, will be presenting the latest results from the crizotinib trial at ASCO. "The strength of crizotinib in ALK positive lung cancer was apparent when less than 20 patients were taking part in the trial. The benefit of targeting this kind of cancer with this particular drug has only been confirmed as more patients enrolled in the trial," said Camidge. "This demonstrates the efficacy of new drugs can be reliably revealed even among small groups of patients when the cancers being tested are molecularly uniform."

Medical oncologists at UCH care for one of the largest groups of ALK positive lung cancer patients in the world. Approximately one in 20 lung cancer patients is ALK positive - their responses to crizotinib are dramatic, the side effects are usually mild and often improve over time.

Camidge believes the results being seen with crizotinib open the door to a new way of thinking when it comes to cancer treatment. "We need to continue testing drugs in mole
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
720-848-7852
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mechanism discovered for health benefit of green tea, new approach to autoimmune disease
2. Radiology benefit managers adversely affect referring physicians, study suggests
3. Acupuncture of benefit to those with unexplained symptoms
4. Trial Stopped After Niacin Brings No Benefit to Heart Patients
5. CT angiography for low-risk heart patients leads to more drugs and tests without benefit
6. CT Heart Scans No Benefit to Patients Without Symptoms
7. Cancer Patients Benefit From Full Access to Medical Records
8. Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment
9. Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds
10. Hospitals misleading patients about benefits of robotic surgery, study suggests
11. Selenium Supplements Might Give Modest Benefit Against Cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... The famous review site Top10BestSEOHosting.com has recently compared many ... suppliers carefully, today it announces that HostMonster, GreenGeeks and ... first half of 2014. , HostMonster is an ... package helps business companies and individuals get high-powered service ... rated hosting provider, it insists on offering outstanding customer ...
(Date:10/18/2014)... (PRWEB) October 19, 2014 ... announced that Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ), JustHost ... suppliers in 2014. , “There are ... world, but good suppliers are not too ... and FatCow are the most outstanding suppliers ...
(Date:10/18/2014)... Operators in the Carpet ... carpet cleaning services, such as steam cleaning, dry-cleaning ... every one to two years. According to IBISWorld ... plummeted during the peak of the global financial ... carpet cleaning.” The upward trend in household discretionary ...
(Date:10/18/2014)... TX (PRWEB) October 18, 2014 ... Chinese Chondroitin sulfate Industry, 2009-2019 is a ... Global and Chinese Chondroitin sulfate industry. The ... Chondroitin sulfate including its classification, application and ... and China’s top manufacturers of Chondroitin sulfate ...
(Date:10/18/2014)... determined dieters can fail if they don,t have a ... Their new study included 240 obese people. All of ... factors that increase the risk of heart disease, stroke ... to make lifestyle changes, including improved eating, the study ... clinical trial comparing two dietary interventions: the American ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: HostMonster, GreenGeeks And FatCow Are The Best PHP Hosting Suppliers In The First Half Of 2014 2Health News:Top10BestSEOHosting.com: Best Reseller Hosting Companies Announced 2Health News:Carpet Cleaning Services in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Carpet Cleaning Services in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 4Health News:Dieters May Be Thwarted by Absence of Healthy Foods 2
... America, Inc. (SAI),today announced the 1,000th activation ... Hagerstown Medical Laboratory, Maryland.,SNCS is a remote ... tracks instrument performance data from Sysmex analyzers ... SNCS enables proactive response to potential,instrument problems, ...
... Medications May Disappear or be Hindered For ... California,s Most Vulnerable Citizens, SACRAMENTO, Calif., ... against the California Department of,Health Care Services and its director ... pharmacies from going into effect on July 1,2008. The action ...
... Raising Awareness ... & Education, NEW YORK, June 10 MGM ... branding initiative, PiNKiTUDE, which,will encompass a wide range of ... earmarked for the global breast cancer organization,Susan G. Komen ...
... June 5, 2008 Over 1.3 million Americans ... of the joints. RA is a disabling condition, and ... pain and loss of function in affected areas. A ... Journal of Periodontology , the official publication of ...
... regimen of the immune-suppressing drug cyclophosphamide seems to slow ... small group of patients studied and may even restore ... report. The findings in nine people, most of whom ... treat a disease that tends to progress relentlessly. , ...
... Promote Health and ... Wellness, ... meeting consumers, health and wellness needs, the Kellogg,Company joined the Department of ... companies,promoting eating and physical fitness for families that is consistent with,MyPyramid. The ...
Cached Medicine News:Health News:Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation 2Health News:Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation 3Health News:Eight California Pharmacies File Lawsuit Against the California Department of Health Care Services to Stop the 10 Percent Medi-Cal Provider Cuts to Pharmacies 2Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 2Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 3Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 4Health News:Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients 2Health News:'HiCy' drug regimen reverses ms symptoms in selected patients 2Health News:'HiCy' drug regimen reverses ms symptoms in selected patients 3Health News:Kellogg and MyPyramid - Helping Families Live Well Today and Every Day 2Health News:Kellogg and MyPyramid - Helping Families Live Well Today and Every Day 3Health News:Kellogg and MyPyramid - Helping Families Live Well Today and Every Day 4
(Date:10/16/2014)... , Oct. 16, 2014 The ... guidance on the application of single-use, or ... pharmaceutical and biopharmaceutical products with the publication ... Application of Single-Use Systems in Pharmaceutical ... described as single-use systems (SUS) or single-use ...
(Date:10/16/2014)... , Oct. 16, 2014 Curtis & ... under 3 weeks away from hosting their co-located ... Oral Drug Formulation Innovations Summit taking place ... San Diego, CA. November,s events ... organizations in streamlining the bioequivalence testing process, as well ...
(Date:10/16/2014)... PHILADELPHIA , Oct. 16, 2014 Ninety ... (ALL) who had relapsed multiple times or failed to ... an investigational personalized cellular therapy, CTL019, developed at the ... The results published today in The ... new data, which builds on preliminary findings presented at ...
Breaking Medicine Technology:PDA Offers Help in Applying Single-Use Systems to Bio/Pharma Operations 2Simplifying the Bioequivalence Testing Process and Optimizing Oral Formulation Development via Unifying the Global Life Science Community this November in San Diego 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 2Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 3Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 4Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 5Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied 6
... Health Corp. (Nasdaq: WBMD ) today announced the ... amount of 2.50% Convertible Notes due 2018 (including $50 million ... full of the initial purchaser,s over-allotment option).  The notes were ... under the Securities Act of 1933.   The ...
... NEW YORK, Jan. 11, 2011 Reportlinker.com ... is available in its catalogue: ... Price cuts set to negatively impact both ... http://www.reportlinker.com/p0360216/Spain-Pharmaceutical-Market-Overview – Price-cuts-set-to-negatively-impact-both-branded-and-generics-companies.html ...
Cached Medicine Technology:WebMD Closes Offering of 2.50% Convertible Notes Due 2018 2Reportlinker Adds Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies 2
... physicians looking for a traditional ... communications with electronic storage features, ... best of both worlds. It ... features of the Atria 3000 ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: